0001104659-22-064838.txt : 20220525 0001104659-22-064838.hdr.sgml : 20220525 20220525204534 ACCESSION NUMBER: 0001104659-22-064838 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220523 FILED AS OF DATE: 20220525 DATE AS OF CHANGE: 20220525 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DUGGAN ROBERT W CENTRAL INDEX KEY: 0001055919 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36866 FILM NUMBER: 22964765 MAIL ADDRESS: STREET 1: 611 SOUTH FORT HARRISON AVE STREET 2: SUITE 306 CITY: CLEARWATER STATE: FL ZIP: 33756 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Summit Therapeutics Inc. CENTRAL INDEX KEY: 0001599298 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-514-7149 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Summit Therapeutics plc DATE OF NAME CHANGE: 20150219 FORMER COMPANY: FORMER CONFORMED NAME: Summit Corp plc DATE OF NAME CHANGE: 20140205 4 1 tm2216975-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-05-23 0 0001599298 Summit Therapeutics Inc. SMMT 0001055919 DUGGAN ROBERT W 611 SOUTH FORT HARRISON AVE SUITE 306 CLEARWATER FL 33756 1 1 0 0 Chief Executive Officer Common Stock 2022-05-23 4 J 0 21135 A 67683589 D The shares of Common Stock were collateral for a loan made by the Reporting Person to a third party, and were transferred to the Reporting Person in full satisfaction of the loan. /s/ Robert W. Duggan_ 2022-05-25